Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value ($000): $434,881 (100.0% shares, 0.0% debt)

Holdings (46)

MEDIVATION INC 8.9%
Value ($000) $38,622 Shares 600,000 Est. Cost $63.87 Unrealized
CUBIST PHARMACEUTICALS INC 5.0%
Value ($000) $21,945 Shares 300,000 Est. Cost $68.87 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 5.0%
Value ($000) $21,609 Shares 207,500 Est. Cost $60.82 Unrealized +93.3%
BMRN BIOMARIN PHARMACEUTICAL INC 4.7%
Value ($000) $20,463 Shares 300,000 Est. Cost $71.76 Unrealized +2.7%
RECEPTOS INC 4.3%
Value ($000) $18,873 Shares 450,000 Est. Cost $31.87 Unrealized
DYAX CORP 4.1%
Value ($000) $17,960 Shares 2,000,000 Est. Cost $7.54 Unrealized
INTERCEPT PHARMACEUTICALS IN 3.8%
Value ($000) $16,490 Shares 50,000 Est. Cost $329.80 Unrealized
ARROWHEAD RESEARCH CORP 3.8%
Value ($000) $16,420 Shares 1,000,000 Est. Cost $10.85 Unrealized
IDENIX PHARMACEUTICALS INC 3.5%
Value ($000) $15,075 Shares 2,500,000 Est. Cost $5.98 Unrealized
PTCT PTC THERAPEUTICS INC 3.3%
Value ($000) $14,377 Shares 550,000 Est. Cost $26.39 Unrealized +1.8%
JAZZ JAZZ PHARMACEUTICALS PLC 3.2%
Value ($000) $13,868 Shares 100,000 Est. Cost $150.52 Unrealized 0.0%
PRTA PROTHENA CORP PLC 3.1%
Value ($000) $13,409 Shares 350,000 Est. Cost $32.24 Unrealized 0.0%
DXCM DEXCOM INC 2.9%
Value ($000) $12,408 Shares 300,000 Est. Cost $7.91 Unrealized +30.6%
BCRX BIOCRYST PHARMACEUTICALS INC 2.8%
Value ($000) $12,357 Shares 1,168,000 Est. Cost $9.67 Unrealized +10.3%
MRK MERCK & CO. INC NEW 2.6%
Value ($000) $11,354 Shares 200,000 Est. Cost $35.76 Unrealized 0.0%
SGMO SANGAMO BIOSCIENCES INC 2.5%
Value ($000) $10,848 Shares 600,000 Est. Cost $17.13 Unrealized +12.6%
ACELRX PHARMACEUTICALS INC 2.1%
Value ($000) $9,008 Shares 750,000 Est. Cost $11.31 Unrealized
SRNE SORRENTO THERAPEUTICS INC 2.1%
Value ($000) $8,974 Shares 700,000 Est. Cost $11.07 Unrealized 0.0%
TESARO INC 2.0%
Value ($000) $8,844 Shares 300,000 Est. Cost $28.24 Unrealized
ALKS ALKERMES PLC 2.0%
Value ($000) $8,818 Shares 200,000 Est. Cost $47.58 Unrealized 0.0%
KARYOPHARM THERAPEUTICS INC 2.0%
Value ($000) $8,649 Shares 280,000 Est. Cost $28.04 Unrealized
CLOVIS ONCOLOGY INC 1.9%
Value ($000) $8,312 Shares 120,000 Est. Cost $60.27 Unrealized
NANOSTRING TECHNOLOGIES INC 1.9%
Value ($000) $8,260 Shares 400,000 Est. Cost $20.65 Unrealized
ARRAY BIOPHARMA INC 1.9%
Value ($000) $8,225 Shares 1,750,000 Est. Cost $5.01 Unrealized
GLYCOMIMETICS INC 1.8%
Value ($000) $7,665 Shares 469,400 Est. Cost $16.33 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.7%
Value ($000) $7,299 Shares 300,000 Est. Cost $23.59 Unrealized +7.2%
CHIMERIX INC 1.6%
Value ($000) $6,852 Shares 300,000 Est. Cost $19.16 Unrealized
OMER OMEROS CORP 1.4%
Value ($000) $6,035 Shares 500,000 Est. Cost $12.28 Unrealized 0.0%
GALT GALECTIN THERAPEUTICS INC 1.2%
Value ($000) $5,328 Shares 348,000 Est. Cost $14.24 Unrealized 0.0%
PORTOLA PHARMACEUTICALS INC 1.2%
Value ($000) $5,180 Shares 200,000 Est. Cost $25.84 Unrealized
EGRX EAGLE PHARMACEUTICALS INC 1.2%
Value ($000) $5,100 Shares 400,000 Est. Cost $13.58 Unrealized 0.0%
ROCKWELL MED INC 1.2%
Value ($000) $5,064 Shares 400,000 Est. Cost $12.66 Unrealized
NOVAVAX INC 1.0%
Value ($000) $4,530 Shares 1,000,000 Est. Cost $5.12 Unrealized
RECRO PHARMA INC 0.8%
Value ($000) $3,660 Shares 500,000 Est. Cost $7.32 Unrealized
GENVEC INC 0.8%
Value ($000) $3,523 Shares 1,329,300 Est. Cost $2.65 Unrealized
PCRX PACIRA PHARMACEUTICALS INC 0.8%
Value ($000) $3,500 Shares 50,000 Est. Cost $52.58 Unrealized +29.4%
ALNY ALNYLAM PHARMACEUTICALS INC 0.8%
Value ($000) $3,357 Shares 50,000 Est. Cost $59.65 Unrealized +29.8%
AGENUS INC 0.7%
Value ($000) $3,170 Shares 1,000,000 Est. Cost $3.17 Unrealized
AQUINOX PHARMACEUTICALS INC 0.7%
Value ($000) $3,143 Shares 246,877 Est. Cost $12.73 Unrealized
GERN GERON CORP 0.7%
Value ($000) $3,135 Shares 1,500,000 Est. Cost $4.29 Unrealized -7.1%
AUSPEX PHARMACEUTICALS INC 0.7%
Value ($000) $3,076 Shares 100,000 Est. Cost $30.76 Unrealized
BIIB BIOGEN IDEC INC 0.7%
Value ($000) $3,059 Shares 10,000 Est. Cost $317.43 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.7%
Value ($000) $2,933 Shares 60,000 Est. Cost $51.48 Unrealized 0.0%
REGULUS THERAPEUTICS INC 0.4%
Value ($000) $1,804 Shares 200,000 Est. Cost $8.21 Unrealized
IDERA PHARMACEUTICALS INC 0.4%
Value ($000) $1,632 Shares 400,000 Est. Cost $4.08 Unrealized
CELSUS THERAPEUTICS PLC 0.2%
Value ($000) $668 Shares 103,000 Est. Cost $6.49 Unrealized